FABP5 and prostate carcinoma: Although functional characterisation work and other studies demonstrated that FABP5 and other FABPs may be prognostic markers and treatment targets for different cancer types, the potential involvement of other FABPs in malignant progression of prostate cancer had not been fully investigated.